{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:ct-nct03986073",
  "owner": "cardio",
  "kind": "study",
  "slug": "nct03986073",
  "name": "Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus",
  "aliases": [
    "NCT03986073"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.",
  "summary_technical": "Registry record NCT03986073. Randomized; quadruple masking; primary purpose treatment. Start 2020-01-01 (actual); primary completion 2020-06-30 (anticipated). Results not posted.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-08",
  "last_evidence_check": null,
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "nct",
      "value": "NCT03986073",
      "normalized_value": "NCT03986073",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "condition-area": [
        "diabetes-and-metabolic-disease"
      ],
      "system": [
        "metabolism"
      ]
    }
  },
  "payload": {
    "design": "Interventional study; randomized; quadruple masking; primary purpose treatment",
    "drug_phase": "2",
    "registry_statuses": [
      {
        "status": "UNKNOWN",
        "snapshot": "cardio:ctgov-nct03986073-2020-03-13"
      }
    ],
    "start_date": {
      "date": "2020-01-01",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct03986073-2020-03-13"
    },
    "primary_completion_date": {
      "date": "2020-06-30",
      "type": "anticipated",
      "snapshot": "cardio:ctgov-nct03986073-2020-03-13"
    },
    "completion_date": {
      "date": "2020-09-30",
      "type": "anticipated",
      "snapshot": "cardio:ctgov-nct03986073-2020-03-13"
    },
    "results_first_posted": null,
    "countries": [
      {
        "code": "CN",
        "snapshot": "cardio:ctgov-nct03986073-2020-03-13"
      }
    ],
    "care_setting": null,
    "stopped_early": null,
    "enrollment": [
      {
        "count": 120,
        "basis": "planned",
        "unit": "participants",
        "snapshot": "cardio:ctgov-nct03986073-2020-03-13"
      }
    ],
    "arms": [],
    "findings": [],
    "registry": [
      {
        "label": "Brief title",
        "value": "Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus",
        "locator": "protocolSection.identificationModule.briefTitle"
      },
      {
        "label": "Condition",
        "value": "Type 2 Diabetes Mellitus",
        "locator": "protocolSection.conditionsModule.conditions[0]"
      },
      {
        "label": "Intervention (Drug)",
        "value": "TQ-F3083 capsule 10 mg",
        "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "TQ-F3083 capsule 20 mg",
        "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "TQ-F3083 blank analog capsule",
        "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "TQ-F3083 blank analog capsule",
        "locator": "protocolSection.armsInterventionsModule.interventions[3].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Linagliptin blank analog tablet",
        "locator": "protocolSection.armsInterventionsModule.interventions[4].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Linagliptin tablet",
        "locator": "protocolSection.armsInterventionsModule.interventions[5].name"
      },
      {
        "label": "Lead sponsor",
        "value": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name"
      },
      {
        "label": "Lead sponsor class",
        "value": "INDUSTRY",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.class"
      }
    ]
  },
  "content_digest": "baa41b5110255bacc35a174ee62c72deae8ed80cd2e7851c78e49a6491be1c32",
  "review": {
    "content_digest": "baa41b5110255bacc35a174ee62c72deae8ed80cd2e7851c78e49a6491be1c32",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "investigates",
        "label": "Registry condition terms include this condition",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:type-2-diabetes",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03986073-2020-03-13",
          "locator": "derivedSection.conditionBrowseModule.meshes[0].id"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "sponsored_by",
        "label": "Registry lists this organization as the lead sponsor",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:org-chia-tai-tianqing-pharmaceutical-group-co-ltd",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03986073-2020-03-13",
          "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name"
        },
        "primary": false,
        "role": "lead",
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": []
  },
  "page_path": "studies/nct03986073/",
  "context_path": "api/v1/context/cardio--ct-nct03986073.md"
}
